BioSpace News Archive

Nearly one year after it was launched by Pfizer and Bain Capital, Cerevel Therapeutics has tapped industry veteran Tony Coles as its chief executive officer.

Do you wake up every morning dreading going to work? If this happens to you even once a week, it may be time to start looking for a new gig.

There are things to negotiate in a job offer other than just money. You can begin your negotiation using this comprehensive guide that will tell you what to do and what not to.

Shares of ACADIA Pharmaceuticals are up nearly 70% after the company announced it halted a Phase III psychosis trial early after its Parkinson’s disease drug Nuplazid hit primary endpoints and positioned the company to seek another potential regulatory approval.

‘iM-TCRs’ enable controllable cytotoxicity of tumor-specific TCR-T cells to potentially tune safety and efficacy according to clinical needs

Nine projects receive funding for cross-sector projects focused on imaging, cancer, neuroscience, and drug discovery/clinical trials

To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM

The Research Hub Includes the First Academic-Industry Drug Discovery Incubator in San Diego

After Joichi “Joi” Ito resigned from his post as director of the MIT Media Lab following revelations of his connections with disgraced financier Jeffrey Epstein, Boston-based Puretech Health announced this morning that he has also resigned from his position as chairman of that company’s board of directors.

There are high hopes for more M&A in the industry for the remainder of the year. Here’s a look at the 10 top takeover targets.